Multiple sclerosis: risk factors, prodromes, and potential causal pathways

Vitamin D Deficiency

Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720 · see citing works

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.

Polman, C., O'Connor, P., Havrdová, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J., Lublin, F., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,293 · see citing works

Multiple Sclerosis

Noseworthy, J. H., Lucchinetti, C. F., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 3,016 · see citing works

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

Hauser, S. L., Waubant, E., Arnold, D. L., Vollmer, T., Antel, J., Fox, R. J., Bar-Or, A., Panzara, M., Sarkar, N., Agarwal, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706383 · Cited by 2,439 · see citing works

A Population-Based Study

Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,290 · see citing works

Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis

Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,899 · see citing works

Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis

Viglietta, V., Baecher‐Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,858 · see citing works

Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study

(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746 · see citing works

Sex differences in autoimmune disease

Whitacre, C. C. (2001) · Nature Immunology · doi:10.1038/ni0901-777 · Cited by 1,271 · see citing works

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

Barkhof, F. (1997) · Brain · doi:10.1093/brain/120.11.2059 · Cited by 1,251 · see citing works

Interleukin-17 Production in Central Nervous System-Infiltrating T Cells and Glial Cells Is Associated with Active Disease in Multiple Sclerosis

Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J. A., Newcombe, J., Esiri, M. M., & Fugger, L. H. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,180 · see citing works

Vitamin D intake and incidence of multiple sclerosis

Munger, K. L., Zhang, S. M., O’Reilly, É. J., Hernán, M. Á., Olek, M. J., Willett, W. C., & Ascherio, A. (2004) · Neurology · doi:10.1212/01.wnl.0000101723.79681.38 · Cited by 1,090 · see citing works

Environmental risk factors for multiple sclerosis. Part I: The role of infection

Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,036 · see citing works

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis

The CAMMS Trial Investigators (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802670 · Cited by 1,012 · see citing works

Multiple sclerosis: a complicated picture of autoimmunity

McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985 · see citing works

Sex ratio of multiple sclerosis in Canada: a longitudinal study

Orton, S. M., Herrera, B. M., Yee, I. M. L., Valdar, W. S. J., Ramagopalan, S. V., Sadovnick, A. D., & Ebers, G. C. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70581-6 · Cited by 922 · see citing works

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

Fisniku, L. K., Brex, P. A., Altmann, D. R., Miszkiel, K. A., Benton, C. E., Lanyon, R., Thompson, A. J., & Miller, D. H. (2008) · Brain · doi:10.1093/brain/awm329 · Cited by 897 · see citing works

Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci

International MS Genetics Consortium, De Jager, P. L., Jia, X., Wang, J., de Bakker, P. I. W., Ottoboni, L., Aggarwal, N. T., Piccio, L., Raychaudhuri, S., Tran, D., et al. (2009) · Nature Genetics · doi:10.1038/ng.401 · Cited by 800 · see citing works

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21141 · Cited by 714 · see citing works

Temporal trends in the incidence of multiple sclerosis

Alonso, Á., & Hernán, M. Á. (2008) · Neurology · doi:10.1212/01.wnl.0000316802.35974.34 · Cited by 695 · see citing works

Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome

Okuda, D. T., Mowry, E. M., Beheshtian, A., Waubant, E., Baranzini, S. E., Goodin, D. S., Hauser, S. L., & Pelletier, D. (2009) · Neurology · doi:10.1212/01.wnl.0000335764.14513.1a · Cited by 642 · see citing works

Regulatory CD56 bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis

Bielekova, B., Catálfamo, M., Reichert-Scrivner, S. A., Packer, A., Černá, M., Waldmann, T. A., McFarland, H. F., Henkart, P. A., & Martinꝉ, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601335103 · Cited by 597 · see citing works

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

Miller, D., Barkhof, F., Montalban, X., Thompson, A., & Filippi, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70071-5 · Cited by 594 · see citing works

Vitamin D and multiple sclerosis

Ascherio, A., Munger, K. L., & Simon, K. C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70086-7 · Cited by 591 · see citing works

Genetics of multiple sclerosis

Dyment, D. A., Ebers, G. C., & Dessa Sadovnick, A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00663-x · Cited by 563 · see citing works

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study

van der Mei, I. A. F., Ponsonby, A., Dwyer, T., Blizzard, L., Simmons, R. D., Taylor, B. V., Butzkueven, H., & Kilpatrick, T. J. (2003) · BMJ · doi:10.1136/bmj.327.7410.316 · Cited by 550 · see citing works

Twin concordance and sibling recurrence rates in multiple sclerosis

Willer, C. J., Dyment, D. A., RISCH, N. J., Sadovnick, A. D., Ebers, G. C., & The Canadian Collaborative Study Group§§ (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1932604100 · Cited by 532 · see citing works

Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis

Thacker, E. L., Mirzaei, F., & Ascherio, A. (2006) · Annals of Neurology · doi:10.1002/ana.20820 · Cited by 517 · see citing works

The epidemiology of multiple sclerosis

Goodin, D. S. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-802973-2.00011-2 · Cited by 517 · see citing works

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

Segal, B. M., Constantinescu, C. S., Raychaudhuri, A., Kim, L., Fidelus-Gort, R., & Kasper, L. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70173-x · Cited by 479 · see citing works

The endophenotype concept in psychiatric genetics

FLINT, J., & MUNAFÒ, M. R. (2007) · Psychological Medicine · doi:10.1017/s0033291706008750 · Cited by 477 · see citing works

HISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS, WITH SPECIAL REFERENCE TO CLINICAL COURSE

Jersild, C., Hansen, G., Svejgaard, A., Fog, T., Thomsen, M., & Dupont, B. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90970-7 · Cited by 467 · see citing works

Timing of birth and risk of multiple sclerosis: population based study

Willer, C. J., Dyment, D. A., Sadovnick, A. D., Rothwell, P. M., Murray, T. J., & Ebers, G. C. (2004) · BMJ · doi:10.1136/bmj.38301.686030.63 · Cited by 451 · see citing works

Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis

Haas, J., Hug, A., Viehöver, A., Fritzsching, B., Falk, C. S., Filser, A., Vetter, T., Milkova, L., Korporal, M., Fritz, B., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526065 · Cited by 450 · see citing works

Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis

Levin, L. I. (2005) · JAMA · doi:10.1001/jama.293.20.2496 · Cited by 446 · see citing works

Body size and risk of MS in two cohorts of US women

Munger, K. L., Chitnis, T., & Ascherio, A. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c0d6e0 · Cited by 441 · see citing works

Toward constructing an endophenotype strategy for bipolar disorders

Hasler, G., Drevets, W. C., Gould, T. D., Gottesman, I. I., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.006 · Cited by 423 · see citing works

Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Tintoré, M., Rovira, À., Martinez, M. J., Río, J., Villoslada, P., Brieva, L., Borrás, C., Grivé, E., Capellades, J., & Montalbán, X. (2000) · PubMed Central · Cited by 419 · see citing works

Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes.

Dalton, C., Chard, D., Davies, G., Miszkiel, K., Altmann, D., Fernando, K., Plant, G., Thompson, A., & Miller, D. H. (2004) · Brain : a journal of neurology · doi:10.1093/brain/awh126 · Cited by 385 · see citing works

Symptomless Cancer in Women

Powley, J. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91052-9 · Cited by 366 · see citing works

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

Tintoré, M., Rovira, A., Río, J., Tur, C., Pelayo, R., Nos, C., Téllez, N., Perkal, H., Comabella, M., Sastre-Garriga, J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000280576.73609.c6 · Cited by 345 · see citing works

Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study

Banwell, B., Krupp, L., Kennedy, J., Tellier, R., Tenembaum, S. N., Ness, J., Belman, A. L., Boiko, A., Быкова, О. В., Waubant, E. L., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70196-5 · Cited by 344 · see citing works

Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis

Hedström, A. K., Bäärnhielm, M., Olsson, T. P., & Alfredsson, L. S. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b59c40 · Cited by 323 · see citing works

Multiple sclerosis. Updated risks for relatives

Sadovnick, A. D., Baird, P. A., Ward, R. H., Optiz, J. M., & Reynolds, J. F. (1988) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320290310 · Cited by 318 · see citing works

Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis

Barcellos, L. F., Sawcer, S. J., Ramsay, P. P., Baranzini, S. E., Thomson, G. J., Briggs, F. B. S., Cree, B., Begovich, A. B., Villoslada, P., Montalbán, X., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl223 · Cited by 312 · see citing works

On the Risk of Multiple Sclerosis According to Age at Immigration to South Africa

Dean, G., & Kurtzke, J. F. (1971) · BMJ · doi:10.1136/bmj.3.5777.725 · Cited by 304 · see citing works

An altered immune response to Epstein-Barr virus in multiple sclerosis

Sundström, P., Juto, P., Wadell, G., Hallmans, G., Svenningsson, A., Nyström, L., Dillner, J., & Forsgren, L. (2004) · Neurology · doi:10.1212/01.wnl.0000130496.51156.d7 · Cited by 302 · see citing works

Cigarette Smoking and Incidence of Multiple Sclerosis

Hernán, M. Á. (2001) · American Journal of Epidemiology · doi:10.1093/aje/154.1.69 · Cited by 299 · see citing works

HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course

Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293 · see citing works

Migrant studies in multiple sclerosis

Galé, C. R., & Martyn, C. (1995) · Progress in Neurobiology · doi:10.1016/0301-0082(95)80008-v · Cited by 289 · see citing works

SOME COMMENTS ON THE RELATIONSHIP OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS TO LATITUDE, SOLAR RADIATION, AND OTHER VARIABLES

Acheson, E. D., Bachrach, C. A., & Wright, F. M. (1960) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1960.tb08674.x · Cited by 278 · see citing works

Epidemiology of multiple sclerosis in U.S. veterans

Kurtzke, J. F., Beebe, G. W., & Norman, J. E. (1979) · Neurology · doi:10.1212/wnl.29.9_part_1.1228 · Cited by 277 · see citing works

Parent-of-origin effect in multiple sclerosis: observations in half-siblings

Ebers, G. C., Sadovnick, A. D., Dyment, D. A., Yee, I., Willer, C. J., & RISCH, N. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16304-6 · Cited by 269 · see citing works

Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it

Vieth, R., Cole, D., HAWKER, G. A., Trang, H., & Rubin, L. A. (2001) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601275 · Cited by 264 · see citing works

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: Results of a randomized, double-blind, placebo-controlled MR-monitored phase II trial

van Oosten, B. W., Lai, M., Hodgkinson, S. J., Barkhof, F., Miller, D., MOSELEY, I. F., Thompson, A. J., Rudge, P., McDougall, A., McLeod, J., et al. (1997) · Neurology · doi:10.1212/wnl.49.2.351 · Cited by 262 · see citing works

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

Jager, P. L. D., Chibnik, L. B., Cui, J., Reischl, J., Lehr, S., Simon, K. C., Aubin, C., Bauer, D., Heubach, J. F., Sandbrink, R., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70275-3 · Cited by 261 · see citing works

Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients

Jacobsen, M., Cepok, S., Quak, E., Happel, M., Gaber, R., Ziegler, A., Schock, S., Oertel, W. H., Sommer, N., & Hemmer, B. (2002) · Brain · doi:10.1093/brain/awf059 · Cited by 253 · see citing works

Smoking and Disease Progression in Multiple Sclerosis

Healy, B. C., Ali, E. N., Guttmann, C. R. G., Chitnis, T., Glanz, B. I., Buckle, G. J., Houtchens, M. K., Stazzone, L., Moodie, J., Berger, A. M., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.122 · Cited by 245 · see citing works

Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance

Dyment, D. A., Herrera, B. M., Cader, M. Z., Willer, C. J., Lincoln, M. R., Sadovnick, A. D., RISCH, N. J., & Ebers, G. C. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi206 · Cited by 243 · see citing works

Annual incidence, prevalence, and mortality of multiple sclerosis in white South-African-born and in white immigrants to South Africa.

Dean, G. (1967) · BMJ · doi:10.1136/bmj.2.5554.724 · Cited by 236 · see citing works

Age–adjusted recurrence risks for relatives of patients with multiple sclerosis

Robertson, N. P., Fraser, M., Deans, J., Clayton, D. G., Walker, N., & Compston, D. A. S. (1996) · Brain · doi:10.1093/brain/119.2.449 · Cited by 234 · see citing works

The age-range of risk of developing multiple sclerosis: Evidence from a migrant population in Australia

Hammond, S. R. (2000) · Brain · doi:10.1093/brain/123.5.968 · Cited by 228 · see citing works

Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosis

Lünemann, J. D., Tintoré, M., Messmer, B., Strowig, T., Rovira, À., Perkal, H., Caballero, E., Münz, C., Montalbán, X., & Comabella, M. (2009) · Annals of Neurology · doi:10.1002/ana.21886 · Cited by 227 · see citing works

High seroprevalence of Epstein–Barr virus in children with multiple sclerosis

Pohl, D., Krone, B., Rostasy, K. M., Kahler, E., Brunner, E., Lehnert, M., Wagner, H., Gärtner, J., & Hanefeld, F. A. (2006) · Neurology · doi:10.1212/01.wnl.0000247665.94088.8d · Cited by 226 · see citing works

Multiple sclerosis in US veterans of the Vietnam era and later military service: race, sex, and geography

Wallin, M. T., Page, W. F., & Kurtzke, J. F. (2004) · Annals of Neurology · doi:10.1002/ana.10788 · Cited by 224 · see citing works

Epigenetics: molecular mechanisms and implications for disease

Handel, A. E., Ebers, G. C., & Ramagopalan, S. V. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.11.003 · Cited by 221 · see citing works

Multiple sclerosis after infectious mononucleosis.

Nielsen, T., Rostgaard, K., Nielsen, N., Koch-Henriksen, N., Haahr, S., Sørensen, P., & Hjalgrim, H. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.72 · Cited by 221 · see citing works

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI

Farrell, R. A., Antony, D., Wall, G., Clark, D. A., Fisniku, L., Swanton, J. K., Khaleeli, Z., Schmierer, K., Miller, D. H., & Giovannoni, G. (2009) · Neurology · doi:10.1212/wnl.0b013e3181aa29fe · Cited by 219 · see citing works

Unsuspected Multiple Sclerosis

Gilbert, J. J., & Sadler, M. (1983) · Archives of Neurology · doi:10.1001/archneur.1983.04050080033003 · Cited by 215 · see citing works

THE EPIDEMIOLOGY OF MULTIPLE SCLEROSIS IN THREE AUSTRALIAN CITIES: PERTH, NEWCASTLE AND HOBART

Hammond, S. R., McLeod, J. G., Millingen, K. S., Stewart‐Wynne, E. G., English, D. R., HOLLAND, J. T., & McCall, M. G. (1988) · Brain · doi:10.1093/brain/111.1.1 · Cited by 211 · see citing works

Multiple sclerosis among United Kingdom-born children of immigrants from the Indian subcontinent, Africa and the West Indies.

Elian, M., Nightingale, S., & Dean, G. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.10.906 · Cited by 205 · see citing works

The Causal Cascade to Multiple Sclerosis: A Model for MS Pathogenesis

Goodin, D. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004565 · Cited by 205 · see citing works

Optic neuritis

Söderström, M. B., Jin, Y., Hillert, J. A., & Link, H. (1998) · Neurology · doi:10.1212/wnl.50.3.708 · Cited by 193 · see citing works

Risk of multiple sclerosis related to age at immigration to Israel.

Alter, M., Leibowitz, U., & Speer, J. (1966) · Archives of Neurology · doi:10.1001/archneur.1966.00470150012002 · Cited by 190 · see citing works

Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis

Dean, G., & Elian, M. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.5.565 · Cited by 179 · see citing works

Cognitive Function in Recent-Onset Demyelinating Diseases

Lyon‐Caen, O., Jouvent, R., Hauser, S. L., Chaunu, M., Benoit, N., Widlöcher, D., & Lhermitte, F. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520110034010 · Cited by 178 · see citing works

Geographic distribution of multiple sclerosis: An update with special reference to Europe and the Mediterranean region

Kurtzke, J. F. (1980) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1980.tb03006.x · Cited by 176 · see citing works

Integrating risk factors

Jager, P. L. D., Simon, K. C., Munger, K. L., Rioux, J. D., Hafler, D. A., & Ascherio, A. (2008) · Neurology · doi:10.1212/01.wnl.0000294325.63006.f8 · Cited by 176 · see citing works

Pathogenic CD8+ T cells in multiple sclerosis

Friese, M. A., & Fugger, L. H. (2009) · Annals of Neurology · doi:10.1002/ana.21744 · Cited by 170 · see citing works

Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility

Lincoln, M. R., Ramagopalan, S. V., Chao, M. J., Herrera, B. M., DeLuca, G. C., Orton, S. M., Dyment, D. A., Sadovnick, A. D., & Ebers, G. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812664106 · Cited by 170 · see citing works

Multiple sclerosis: the environment and causation

Giovannoni, G., & Ebers, G. C. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32815610c2 · Cited by 169 · see citing works

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis

Jilek, S., Schluep, M., Meylan, P. R., Vingerhoets, F. J. G., Guignard, L., Monney, A., Kleeberg, J., Goff, G. L., Pantaleo, G., & Pasquier, R. D. (2008) · Brain · doi:10.1093/brain/awn108 · Cited by 169 · see citing works

Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates

Freedman, D. M., Dosemeci, M., & Alavanja, M. C. R. (2000) · Occupational and Environmental Medicine · doi:10.1136/oem.57.6.418 · Cited by 168 · see citing works

Multiple sclerosis immunology

Kasper, L. H., & Shoemaker, J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c97c8f · Cited by 167 · see citing works

HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis

Hensiek, A. E. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.184 · Cited by 167 · see citing works

Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.

Benczur, M., Petrányl, G. G., Pálffy, G., Varga, M., Tálas, M., Kotsy, B., Földeş, I., & Hollán, S. R. (1980) · PubMed Central · Cited by 165 · see citing works

Pediatric multiple sclerosis

Yeh, E. A., Chitnis, T., Krupp, L., Ness, J., Chabas, D., Kuntz, N. L., & Waubant, E. L. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.158 · Cited by 155 · see citing works

Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia

Marrosu, M. G. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2907 · Cited by 154 · see citing works

Smoking is a risk factor for multiple sclerosis: a metanalysis

Hawkes, C. H. (2007) · Multiple Sclerosis Journal · doi:10.1177/1352458506073501 · Cited by 149 · see citing works

Role of return migration in the emergence of multiple sclerosis in the French West Indies

Cabre, P., Signaté, A., Olindo, S., Merle, H., Caparros-Lefebvre, D., Béra, O., & Smadja, D. (2005) · Brain · doi:10.1093/brain/awh624 · Cited by 145 · see citing works

Smoking is a risk factor for early conversion to clinically definite multiple sclerosis

Pauli, F. D., Reindl, M., Ehling, R., Schautzer, F., Gneiss, C., Lutterotti, A., O’Reilly, É., Munger, K. L., Deisenhammer, F., Ascherio, A., et al. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508093679 · Cited by 141 · see citing works

Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta

Saraste, M., Irjala, H., & Airas, L. M. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0803-3 · Cited by 139 · see citing works

Potentially modifiable determinants of vitamin D status in an older population in the Netherlands: the Hoorn Study

van Dam, R. M., Snijder, M. B., Dekker, J. M., Stehouwer, C. D. A., Bouter, L. M., Heine, R. J., & Lips, P. T. A. M. (2007) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.3.755 · Cited by 138 · see citing works

Increasing prevalence and incidence of multiple sclerosis in South East Wales

Hirst, C. L., Ingram, G., Pickersgill, T. P., Swingler, R. J., Compston, D. A. S., & Robertson, N. P. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.144667 · Cited by 138 · see citing works

The regulatory role of natural killer cells in multiple sclerosis

Takahashi, K. (2004) · Brain · doi:10.1093/brain/awh219 · Cited by 133 · see citing works

The Inheritance of Resistance Alleles in Multiple Sclerosis

Ramagopalan, S. V., Morris, A. P., Dyment, D. A., Herrera, B. M., DeLuca, G. C., Lincoln, M. R., Orton, S. M., Chao, M. J., Sadovnick, A. D., & Ebers, G. C. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030150 · Cited by 132 · see citing works

Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile

Lebrun‐Frénay, C., Bensa, C., Debouverie, M., Seze, J. D., Wiertlievski, S., Brochet, B., Clavelou, P., Brassat, D., Labauge, P. M., Roullet, E., et al. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.108274 · Cited by 131 · see citing works

Epidemiology of multiple sclerosis in US veterans

Kurtzke, J. F., Beebe, G. W., & Norman, J. E. (1985) · Neurology · doi:10.1212/wnl.35.5.672 · Cited by 128 · see citing works

Multiple Sclerosis in Israel

Alter, M. (1962) · Archives of Neurology · doi:10.1001/archneur.1962.04210040005001 · Cited by 126 · see citing works

Multiple sclerosis characteristics in A frican A merican patients in the New York State Multiple Sclerosis C onsortium

Weinstock‐Guttman, B., Jacobs, L., Brownscheidle, C. M., Baier, M. L., Rea, D. F., Apatoff, B. R., Blitz-Shabbir, K. M., Coyle, P. K., Frontera, A. T., Goodman, A. D., et al. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms909oa · Cited by 125 · see citing works

Natural killer type 2 bias in remission of multiple sclerosis

Takahashi, K., Miyake, S., Kondo, T., Terao, K., Hatakenaka, M., Hashimoto, S., & Yamamura, T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11819 · Cited by 120 · see citing works

Epidemiology of Multiple Sclerosis in US Veterans

Page, W. F., Mack, T. M., Kurtzke, J. F., Murphy, F. M., & Norman, J. E. (1995) · Neuroepidemiology · doi:10.1159/000109804 · Cited by 119 · see citing works

Multiple sclerosis among immigrants in Greater London.

Dean, G., McLoughlin, H., Brady, R., Adelstein, A. M., & Tallett-Williams, J. (1976) · BMJ · doi:10.1136/bmj.1.6014.861 · Cited by 116 · see citing works

Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis

Celius, E. G., Harbo, H. F., EGELAND, T., Vartdal, F., Vandvik, B., & Spurkland, A. (2000) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(00)00389-0 · Cited by 116 · see citing works

Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event

Corvol, J., Pelletier, D., Henry, R., Caillier, S., Wang, J. H., Pappas, D., Casazza, S., Okuda, D., Hauser, S., Oksenberg, J., et al. (2008) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0805065105 · Cited by 115 · see citing works

A clinical patho-anatomical study of clinically silent multiple sclerosis

Engell, T. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03811.x · Cited by 114 · see citing works

Monoclonal antibodies in MS

Bielekova, B., & Becker, B. L. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c97ed3 · Cited by 111 · see citing works

Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis.

Fernando, K., Tozer, D., Miszkiel, K., Gordon, R., Swanton, J., Dalton, C., Barker, G., Plant, G., Thompson, A., & Miller, D. H. (2005) · Brain : a journal of neurology · doi:10.1093/brain/awh654 · Cited by 111 · see citing works

Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis

Nielsen, T., Rostgaard, K., Askling, J., Steffensen, R., Oturai, A. B., Jersild, C., Koch‐Henriksen, N., Sørensen, P. S., & Hjalgrim, H. (2009) · Multiple Sclerosis Journal · doi:10.1177/1352458508100037 · Cited by 108 · see citing works

Age of puberty and the risk of multiple sclerosis: a population based study

Ramagopalan, S. V., Valdar, W. S. J., Criscuoli, M. G., DeLuca, G. C., Dyment, D. A., Orton, S. M., Yee, I. M. L., Ebers, G. C., Sadovnick, A. D., & for the Canadian Collaborative Study Group (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02431.x · Cited by 107 · see citing works

Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor α-chain are excluded from the analysis

Michel, L., Berthelot, L., Pettré, S., Wiertlewski, S., Lefrère, F., Braudeau, C., Brouard, S., Soulillou, J., & Laplaud, D. A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35365 · Cited by 106 · see citing works

Vitamin D: A Candidate for the Environmental Effect in Multiple Sclerosis – Observations from Norway

Kampman, M. T., & Brustad, M. (2008) · Neuroepidemiology · doi:10.1159/000122330 · Cited by 106 · see citing works

Differential twin concordance for multiple sclerosis by latitude of birthplace

Islam, T. S., Gauderman, W. J., Cozen, W., Hamilton, A. S., Burnett, M. E., & Mack, T. M. (2006) · Annals of Neurology · doi:10.1002/ana.20871 · Cited by 106 · see citing works

Predicting the Outcome of Optic Neuritis

Nilsson, P., Larsson, E., Sundgren, P. C., Perfekt, R., & Sandberg‐Wollheim, M. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0655-9 · Cited by 97 · see citing works

Association of Infectious Mononucleosis with Multiple Sclerosis

Ramagopalan, S. V., Valdar, W. S. J., Dyment, D. A., DeLuca, G. C., Yee, I. M. L., Giovannoni, G., Ebers, G. C., & Sadovnick, A. D. (2009) · Neuroepidemiology · doi:10.1159/000201564 · Cited by 96 · see citing works

Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex

Chao, M., Ramagopalan, S. V., Herrera, B. M., Lincoln, M. R., Dyment, D. A., Sadovnick, A. D., & Ebers, G. C. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn353 · Cited by 96 · see citing works

A role for natural killer cells in the immunopathogenesis of multiple sclerosis

Kastrukoff, L. F., Morgan, N., Zecchini, D., White, R., Petkau, A. J., Satoh, J., & Paty, D. W. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00014-9 · Cited by 94 · see citing works

Mental change as an early feature of multiple sclerosis

Young, A. C., Saunders, J. A., & Ponsford, J. R. (1976) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.39.10.1008 · Cited by 89 · see citing works

Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway

Smestad, C., Sandvik, L., Holmøy, T., Harbo, H. F., & Celius, E. G. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0659-8 · Cited by 87 · see citing works

Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies.

Elian, M., & Dean, G. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.3.327 · Cited by 86 · see citing works

Clinical relapses of multiple sclerosis are associated with ‘novel’ valleys in natural killer cell functional activity

Kastrukoff, L. F., Lau, A. S., Wee, R., Zecchini, D., White, R., & Paty, D. W. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.001 · Cited by 86 · see citing works

Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells

Jager, P. L. D., Rossin, E. J., Pyne, S., Tamayo, P., Ottoboni, L., Viglietta, V., Weiner, M., Soler, D. F., Izmailova, E. S., Faron-Yowe, L., et al. (2008) · Brain · doi:10.1093/brain/awn118 · Cited by 80 · see citing works

Parent-of-origin effects in MS

Herrera, B. M., Ramagopalan, S. V., Lincoln, M. R., Orton, S. M., Chao, M., Sadovnick, A. D., & Ebers, G. C. (2008) · Neurology · doi:10.1212/01.wnl.0000312377.50395.00 · Cited by 73 · see citing works

Maternal Transmission of Multiple Sclerosis in a Dutch Population

Hoppenbrouwers, I. A., Liu, F., Aulchenko, Y. S., Ebers, G. C., Oostra, B. A., van Duijn, C. M., & Hintzen, R. Q. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.63 · Cited by 70 · see citing works

Imaging brain damage in first‐degree relatives of sporadic and familial multiple sclerosis

Stefano, N. D., Cocco, E. E., Lai, M., Battaglini, M., Spissu, A., Marchi, P., Floris, G., Mortilla, M., Stromillo, M. L., Paolillo, A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20767 · Cited by 69 · see citing works

Multiple sclerosis among Orientals and Caucasians in Hawaii

Alter, M., Okihiro, M. M., Rowley, W., & Morris, T. (1971) · Neurology · doi:10.1212/wnl.21.2.122 · Cited by 67 · see citing works

Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls

Munschauer, F. E., Hartrich, L., Stewart, C. C., & Jacobs, L. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00115-9 · Cited by 66 · see citing works

CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis

Jilek, S., Schluep, M., Rossetti, A. O., Guignard, L., Goff, G. L., Pantaleo, G., & Pasquier, R. D. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.11.004 · Cited by 64 · see citing works

Multiple sclerosis in North African migrants to France

Kurtzke, J. F., Delasnerie-Lauprêtre, N., & Wallin, M. T. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb01738.x · Cited by 63 · see citing works

The Schizophrenia Prodrome

White, T. J. H., Anjum, A., & Schulz, S. C. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.3.376 · Cited by 62 · see citing works

Timing of Birth and Risk of Multiple Sclerosis in the Scottish Population

Bayes, H. K., Weir, C. J., & O’Leary, C. (2009) · European Neurology · doi:10.1159/000268163 · Cited by 60 · see citing works

EBNA-1 reactivity and HLA DRB1*1501 as statistically independent risk factors for multiple sclerosis: a case-control study

Sundström, P., Nyström, L., Jidell, E., & Hallmans, G. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508092353 · Cited by 55 · see citing works

Seasonal fluctuation of multiple sclerosis births in Sardinia

Sotgiu, S., Pugliatti, M., Sotgiu, M. A., Fois, M. L., Arru, G., Sanna, A., & Rosati, G. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0917-6 · Cited by 54 · see citing works

Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls

Haghighi, S., Andersen, O., Rosengren, L., Bergström, T. B., Wahlström, J., & Nilsson, S. (2000) · Journal of Neurology · doi:10.1007/s004150070130 · Cited by 52 · see citing works

Natural killer cell number and activity in multiple sclerosis

Vraneš, Z., Poljaković, Z., & Marušić, M. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90222-0 · Cited by 50 · see citing works

Evidence of Early Childhood as the Susceptibility Period in Multiple Sclerosis: Space-Time Cluster Analysis in a Sardinian Population

Pugliatti, M., Riise, T., Sotgiu, M. A., Satta, W. M., Sotgiu, S., Pirastru, M. I., & Rosati, G. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj190 · Cited by 49 · see citing works

Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS

Hauser, S. L., Oksenberg, J. R., Lincoln, R., Garovoy, J., Beck, R. W., Cole, S. R., Moke, P. S., Kip, K. E., Gal, R. L., Long, D. T., et al. (2000) · Neurology · doi:10.1212/wnl.54.9.1859 · Cited by 47 · see citing works

Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients

Rinaldi, L. (2006) · Brain · doi:10.1093/brain/awl179 · Cited by 43 · see citing works

The influence of HLA-DR and -DQ alleles on progression to multiple sclerosis following a clinically isolated syndrome

Kelly, M. A., Cavan, D. A., Penny, M. A., Mijovic, C. H., Jenkins, D. J. A., Morrissey, S., Miller, D. H., Barnett, A. H., & Francis, D. A. (1993) · Human Immunology · doi:10.1016/0198-8859(93)90184-3 · Cited by 42 · see citing works

The Frequency of Multiple Sclerosis in Jewish and Arab Populations in Greater Jerusalem

Karni, A., Kahana, E., Zilber, N., Abramsky, O., Alter, M., & Karussis, D. M. (2003) · Neuroepidemiology · doi:10.1159/000067101 · Cited by 42 · see citing works

Multiple sclerosis

Antel, J. P., Rosenkoetter, M., Reder, A. T., Oger, J. J.-F., & Arnason, B. G. W. (1984) · Neurology · doi:10.1212/wnl.34.9.1155 · Cited by 41 · see citing works

HLA-DRB1 and multiple sclerosis in Malta

Dean, G., Yeo, T. W., Goris, A., Taylor, C. J., Goodman, R. S., Elian, M., Debono, A. G., Aquilina, A., Felice, A. E., Vella, M., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000284598.98525.d7 · Cited by 41 · see citing works

Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis: A Consensus Statement

Freedman, M. S., Thompson, E. J., Deisenhammer, F., Giovannoni, G., Grimsley, G., Keir, G., Öhman, S., Racke, M. K., Sharief, M., Sindic, C. J. M., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.6.865 · Cited by 41 · see citing works

Parent-of-origin effect in multiple sclerosis

Ramagopalan, S. V., Yee, I. M. L., Dyment, D. A., Orton, S. M., Marrie, R. A., Sadovnick, A. D., & Ebers, G. C. (2009) · Neurology · doi:10.1212/wnl.0b013e3181af33cf · Cited by 38 · see citing works

Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS

Duong, M., Audoin, B., Fur, Y. L., Confort-Gouny, S., Malikova, I., Soulier, E., Viout, P., Ali‐Chérif, A., Pelletier, J., Cozzone, P., et al. (2007) · Journal of Neurology · doi:10.1007/s00415-006-0474-7 · Cited by 37 · see citing works

A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS

Rovaris, M., Judica, E., Ceccarelli, A., Ghezzi, A., Martinelli, V., Comi, G. P., & Filippi, M. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0877-8 · Cited by 35 · see citing works

Enumeration of T, B and Natural Killer Peripheral Blood Cells of Patients with Multiple Sclerosis and Controls

Kreuzfelder, E., Shen, G., Bittorf, M., Scheiermann, N., Thraenhart, O., Seidel, D. U., & Grosse‐Wilde, H. (2008) · European Neurology · doi:10.1159/000116820 · Cited by 29 · see citing works

Natural Killer Cell Activity in Patients with Multiple Sclerosis: Interferon and Plasmapheresis

Uchida, A., Maida, E. M., Lenzhofer, R., & Micksche, M. (1982) · Immunobiology · doi:10.1016/s0171-2985(82)80003-x · Cited by 28 · see citing works

Characterization of CD8+ T cell repertoire in identical twins discordant and concordant for multiple sclerosis

Somma, P., Ristori, G., Battistini, L., Cannoni, S., Borsellino, G., Diamantini, A., Salvetti, M., Sorrentino, R., & Fiorillo, M. T. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0906584 · Cited by 26 · see citing works

Evoked potential testing in relatives of multiple sclerosis patients

Nuwer, M. R., Visscher, B. R., Packwood, J. W., & Namerow, N. S. (1985) · Annals of Neurology · doi:10.1002/ana.410180106 · Cited by 23 · see citing works

Natural cytotoxic activity in multiple sclerosis patients: defects in IL-2/interferon gamma-regulatory circuit.

Braakman, E., van Tunen, A., Meager, A., & Lucas, C. J. (1986) · PubMed Central · Cited by 18 · see citing works

MULTIPLE SCLEROSIS IN ISRAEL

Acheson, E. D. (1970) · The Lancet · doi:10.1016/s0140-6736(70)91545-x · Cited by 13 · see citing works

CSF analysis in suspected MS

Hintzen, R. Q., & Giovannoni, G. (2008) · Neurology · doi:10.1212/01.wnl.0000306413.29367.82 · Cited by 9 · see citing works

Untitled work

Khan (2000) · doi:10.1002/1531-8249(200008)48:2

Multiple sclerosis – a review

Dobson, R., & Giovannoni, G. (2018) · European Journal of Neurology · doi:10.1111/ene.13819 · Cited by 2,216 · see citing works

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis

Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 752 · see citing works

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses

Belbasis, L., Bellou, V., Εvangelou, Ε., Ioannidis, J. P. A., & Tzoulaki, I. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70267-4 · Cited by 669 · see citing works

Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy

Muzio, L., Viotti, A., & Martino, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742065 · Cited by 581 · see citing works

Perimenopause as a neurological transition state

Brinton, R. D., Yao, J., Yin, F., Mack, W. J., & Cadenas, E. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.82 · Cited by 612 · see citing works

Epidemiology of multiple sclerosis

Leray, E., Moreau, T., Fromont, A., & Edan, G. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2015.10.006 · Cited by 478 · see citing works

SYK coordinates neuroprotective microglial responses in neurodegenerative disease

Ennerfelt, H., Frost, E. L., Shapiro, D. A., Holliday, C., Zengeler, K. E., Voithofer, G., Bolte, A. C., Lammert, C. R., Kulas, J. A., Ulland, T. K., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.030 · Cited by 329 · see citing works

Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study

Banwell, B., Bar‐Or, A., Arnold, D. L., Sadovnick, A. D., Narayanan, S., McGowan, M., O’Mahony, J., de Magalhaes, S. L. B., Hanwell, H., Vieth, R., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70045-x · Cited by 320 · see citing works

Epigenome-wide differences in pathology-free regions of multiple sclerosis–affected brains

Huynh, J. L., Garg, P., Thin, T. H., Yoo, S., Dutta, R., Trapp, B. D., Haroutunian, V. H., Zhu, J., Donovan, M. J., Sharp, A. J., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3588 · Cited by 273 · see citing works

Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study

Kuhle, J., Disanto, G., Dobson, R., Adiutori, R., Bianchi, L., Topping, J., Bestwick, J., Meier, U.-C., Marta, M., Costa, G. D., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514568827 · Cited by 299 · see citing works

Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke

Lopes Pinheiro, M. A., Kooij, G., Mizee, M. R., Kamermans, A., Enzmann, G., Lyck, R., Schwaninger, M., Engelhardt, B., & de Vries, H. E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.018 · Cited by 247 · see citing works

Dynamic I maging of I ndividual R emyelination P rofiles in M ultiple S clerosis

Bodini, B., Veronese, M., García-Lorenzo, D., Battaglini, M., Poirion, É., Chardain, A., Freeman, L. A., Louapre, C., Tchikviladzé, M., Papeix, C., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24620 · Cited by 240 · see citing works

Protein folding stress in neurodegenerative diseases: a glimpse into the ER

Matus, S., Glimcher, L. H., & Hetz, C. A. (2011) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2011.01.003 · Cited by 222 · see citing works

The evidence for a role of B cells in multiple sclerosis

Disanto, G., Morahan, J. M., Barnett, M. H., Giovannoni, G., & Ramagopalan, S. V. (2012) · Neurology · doi:10.1212/wnl.0b013e318249f6f0 · Cited by 222 · see citing works

Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle

Chidambaram, S. B., Essa, M. M., Rathipriya, A. G., Bishir, M., Ray, B., Mahalakshmi, A. M., Tousif, A. H., Sakharkar, M. K., Kashyap, R. S., Friedland, R. P., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107988 · Cited by 204 · see citing works

The Role of Viral Infections in the Onset of Autoimmune Diseases

Sundaresan, B., Shirafkan, F., Ripperger, K., & Rattay, K. (2023) · Viruses · doi:10.3390/v15030782 · Cited by 194 · see citing works

Oligodendrogenesis in the normal and pathological central nervous system

Waly, B. E., Macchi, M., Cayre, M., & Durbec, P. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00145 · Cited by 176 · see citing works

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis

Pakpoor, J., Disanto, G., Gerber, J. E., Dobson, R., Meier, U., Giovannoni, G., & Ramagopalan, S. (2013) · Multiple Sclerosis · doi:10.1177/1352458512449682 · Cited by 179 · see citing works

The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude

Dobson, R., Giovannoni, G., & Ramagopalan, S. V. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303934 · Cited by 160 · see citing works

Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research

Waldman, A. T., Ghezzi, A., Bar‐Or, A., Mikaeloff, Y., Tardieu, M., & Banwell, B. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70093-6 · Cited by 159 · see citing works

Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study

Wijnands, J. M. A., Kingwell, E., Zhu, F., Zhao, Y., Högg, T., Stadnyk, K., Ekuma, O., Lu, X., Evans, C. D., Fisk, J. D., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30076-5 · Cited by 154 · see citing works

Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment

Huynh, J. L., & Casaccia, P. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70309-5 · Cited by 151 · see citing works

Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop

Amato, M. P., Derfuss, T. J., Hemmer, B., Liblau, R., Montalbán, X., Sørensen, P. S., Miller, D. H., For the 2016 ECTRIMS Focused Workshop Group, Alfredsson, L. S., Aloisi, F., et al. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458516686847 · Cited by 143 · see citing works

Epidemiology of Multiple Sclerosis: Global, Regional, National and Sub-National-Level Estimates and Future Projections

Khan, G., & Hashim, M. J. (2025) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-025-00353-6 · Cited by 153 · see citing works

Epigenetics of Multiple Sclerosis: An Updated Review

Küçükali, C. İ., Kürtüncü, M., Çoban, A., Çebi, M., & Tüzün, E. (2014) · NeuroMolecular Medicine · doi:10.1007/s12017-014-8298-6 · Cited by 135 · see citing works

Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities

Miljković, D. M., & Spasojević, I. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5068 · Cited by 136 · see citing works

Race and ethnicity on MS presentation and disease course

Amezcua, L., & McCauley, J. L. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458519887328 · Cited by 137 · see citing works

Month of birth, vitamin D and risk of immune-mediated disease: a case control study

Disanto, G., Chaplin, G., Morahan, J. M., Giovannoni, G., Hyppönen, E., Ebers, G. C., & Ramagopalan, S. V. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-69 · Cited by 133 · see citing works

Immunizations and risk of multiple sclerosis: systematic review and meta-analysis

Farez, M., & Correale, J. D. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5984-2 · Cited by 132 · see citing works

Myelin quantification with MRI: A systematic review of accuracy and reproducibility

van der Weijden, C. W. J., García, D. V., Borra, R., Thurner, P., Meilof, J., van Laar, P. V., Dierckx, R., Gutmann, I. W., & de Vries, E. D. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117561 · Cited by 118 · see citing works

Breastfeeding and autoimmunity: Programing health from the beginning

Borba, V. V., Sharif, Κ., & Shoenfeld, Y. (2017) · American Journal of Reproductive Immunology · doi:10.1111/aji.12778 · Cited by 129 · see citing works

Parenchymal accumulation of CD163+ macrophages/microglia in multiple sclerosis brains

Zhang, Z., Zhang, Z., Schittenhelm, J., Wu, Y., Meyermann, R., & Schluesener, H. J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.06.006 · Cited by 124 · see citing works

Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review

Morshedi, M., Hashemi, R., Moazzen, S., Sahebkar, A., & Hosseinifard, E.-S. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1611-4 · Cited by 125 · see citing works

The Role of Vitamins in Neurodegenerative Disease: An Update

Nand, S., Singh, P., Steinbusch, H. W. M., Vamanu, E., Ashraf, G. M., & Singh, M. P. (2021) · Biomedicines · doi:10.3390/biomedicines9101284 · Cited by 126 · see citing works

Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review

McKay, K. A., Jahanfar, S., Duggan, T., Tkachuk, S., & Tremlett, H. L. (2016) · NeuroToxicology · doi:10.1016/j.neuro.2016.03.020 · Cited by 121 · see citing works

Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models

Khan, N., & Smith, M. T. (2013) · Inflammopharmacology · doi:10.1007/s10787-013-0195-3 · Cited by 121 · see citing works

Systematic Review and Meta-Analysis of the Sero-Epidemiological Association between Epstein Barr Virus and Multiple Sclerosis

Almohmeed, Y. H., Avenell, A., Aucott, L. S., & Vickers, M. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061110 · Cited by 119 · see citing works

Neuroinflammatory priming to stress is differentially regulated in male and female rats

Fonken, L. K., Frank, M. G., Gaudet, A. D., D’Angelo, H. M., Daut, R. A., Hampson, E. C., Ayala, M. T., Watkins, L. R., & Maier, S. F. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.005 · Cited by 115 · see citing works

Impact of B cells to the pathophysiology of multiple sclerosis

Arneth, B. M. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1517-1 · Cited by 113 · see citing works

Gut environment-induced intraepithelial autoreactive CD4+ T cells suppress central nervous system autoimmunity via LAG-3

Kadowaki, A., Miyake, S., Saga, R., Chiba, A., Mochizuki, H., & Yamamura, T. (2016) · Nature Communications · doi:10.1038/ncomms11639 · Cited by 102 · see citing works

Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism

Kočovská, E., Gaughran, F., Krivoy, A., & Meier, U. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00047 · Cited by 102 · see citing works

May Diet and Dietary Supplements Improve the Wellness of Multiple Sclerosis Patients? A Molecular Approach

Riccio, P., Rossano, R., & Liuzzi, G. M. (2010) · Autoimmune Diseases · doi:10.4061/2010/249842 · Cited by 101 · see citing works

CD46 in innate and adaptive immunity: an update

Cardone, J., Friec, G. L., & Kemper, C. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04400.x · Cited by 98 · see citing works

Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis

Dobson, R., & Giovannoni, G. (2013) · Journal of Neurology · doi:10.1007/s00415-012-6790-1 · Cited by 93 · see citing works

Heterogeneity in Multiple Sclerosis: Scratching the Surface of a Complex Disease

Disanto, G., Berlanga‐Taylor, A. J., Handel, A. E., Para, A. E., Burrell, A., Fries, A., Handunnetthi, L., DeLuca, G. C., & Morahan, J. M. (2010) · Autoimmune Diseases · doi:10.4061/2011/932351 · Cited by 92 · see citing works

Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot study

Irish, A. K., Erickson, C., Wahls, T. L., Snetselaar, L. G., & Darling, W. G. (2017) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s116949 · Cited by 90 · see citing works

Lymph node dissection – understanding the immunological function of lymph nodes

Büettner, M., & Bode, U. (2012) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2012.04602.x · Cited by 90 · see citing works

From the prodromal stage of multiple sclerosis to disease prevention

Marrie, R. A., Allegretta, M., Barcellos, L. F., Bebo, B. F., Calabresi, P. A., Correale, J. D., Davis, B. G., Jager, P. L. D., Gasperi, C., Greenbaum, C. J., et al. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00686-x · Cited by 89 · see citing works

Expression of HERV-Fc1, a Human Endogenous Retrovirus, Is Increased in Patients with Active Multiple Sclerosis

Laska, M. J., Brudek, T., Nissen, K. K., Christensen, T., Møller-Larsen, A., Petersen, T., & Nexø, B. A. (2012) · Journal of Virology · doi:10.1128/jvi.06723-11 · Cited by 86 · see citing works

Environmental Factors in Multiple Sclerosis: Epstein‐Barr Virus, Vitamin D, and Cigarette Smoking

Wingerchuk, D. M. (2011) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20240 · Cited by 85 · see citing works

Targets of the humoral autoimmune response in multiple sclerosis

Fraussen, J., Claes, N., Bock, L., & Somers, V. A. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.07.002 · Cited by 84 · see citing works

Update in vitamin D and multiple sclerosis

Alharbi, F. M. (2015) · Neurosciences · doi:10.17712/nsj.2015.4.20150357 · Cited by 82 · see citing works

Deciphering the Role of B Cells in Multiple Sclerosis—Towards Specific Targeting of Pathogenic Function

Lehmann‐Horn, K., Häusser‐Kinzel, S., & Weber, M. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102048 · Cited by 81 · see citing works

Stem Cell Transplantation Therapy and Neurological Disorders: Current Status and Future Perspectives

Rahman, M. M., Islam, M. R., Islam, M. T., Harun-Or-Rashid, M., Islam, M., Abdullah, S., Uddin, M. B., Das, S., Rahaman, M. S., Ahmed, M., et al. (2022) · Biology · doi:10.3390/biology11010147 · Cited by 63 · see citing works

PI3Kδ drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation

Haylock‐Jacobs, S., Comerford, I., Bunting, M. D., Kara, E. E., Townley, S. L., Klingler‐Hoffmann, M., Vanhaesebroeck, B., Puri, K. D., & McColl, S. R. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.02.006 · Cited by 80 · see citing works

Multiple Sclerosis

Miller, E. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_17 · Cited by 77 · see citing works

The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options

Disanto, G., Benkert, P., Lorscheider, J., Mueller, S., Vehoff, J., Zecca, C., Ramseier, S., Achtnichts, L., Findling, O., Nedeltchev, K., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0152347 · Cited by 76 · see citing works

Ultra-high-field 7T MRI reveals changes in human medial temporal lobe volume in female adults during menstrual cycle

Zsido, R. G., Williams, A. N., Barth, C., Serio, B., Kurth, L., Mildner, T., Trampel, R., Beyer, F., Witte, A. V., Villringer, A., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00125-w · Cited by 76 · see citing works

The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis

Weiland, T. J., Hadgkiss, E. J., Jelinek, G. A., Pereira, N. G., Marck, C. H., & van der Meer, D. M. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.10.046 · Cited by 75 · see citing works

New Markers of Early Cardiovascular Risk in Multiple Sclerosis Patients: Oxidized-LDL Correlates with Clinical Staging

Palavra, F., Marado, D., Mascarenhas‐Melo, F., Sereno, J., Teixeira‐Lemos, E., Nunes, C. C., Gonçalves, G., Teixeira, F. J., & Reis, F. (2013) · Disease Markers · doi:10.1155/2013/567162 · Cited by 74 · see citing works

More highly myelinated white matter tracts are associated with faster processing speed in healthy adults

Chopra, S., Shaw, M. E., Shaw, T. B., Sachdev, P. S., Anstey, K. J., & Cherbuin, N. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.12.069 · Cited by 68 · see citing works

DNA methylation in demyelinated multiple sclerosis hippocampus

Chomyk, A. M., Volsko, C. M., Tripathi, A. K., Deckard, S. A., Trapp, B. D., Fox, R. J., & Dutta, R. (2017) · Scientific Reports · doi:10.1038/s41598-017-08623-5 · Cited by 69 · see citing works

Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis

Meier, U., Cipian, R. C., Karimi, A., Ramasamy, R., & Middeldorp, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.757302 · Cited by 75 · see citing works

An Overview of the History, Pathophysiology, and Pharmacological Interventions of Multiple Sclerosis

Dighriri, I. M., Aldalbahi, A. A., Albeladi, F. I., Tahiri, A. A., Kinani, E. M., Almohsen, R. A., Alamoudi, N. H., Alanazi, A. I., Alkhamshi, S. J., Althomali, N. A., et al. (2023) · Cureus · doi:10.7759/cureus.33242 · Cited by 83 · see citing works

Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS)

Khorshidahmad, T., Acosta, C., Cortes, C., Lakowski, T. M., Gangadaran, S., & Namaka, M. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9074-1 · Cited by 71 · see citing works

Reduced Plasma Levels of 25-Hydroxycholesterol and Increased Cerebrospinal Fluid Levels of Bile Acid Precursors in Multiple Sclerosis Patients

Crick, P. J., Griffiths, W. J., Zhang, J., Beibel, M., Abdel‐Khalik, J., Kühle, J., Sailer, A. W., & Wang, Y. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0281-9 · Cited by 70 · see citing works

Gene–environment interaction in autoimmune disease

Ellis, J. A., Kemp, A., & Ponsonby, A. (2014) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.5 · Cited by 68 · see citing works

Dipeptidyl peptidase in autoimmune pathophysiology

Ohnuma, K., Hosono, O., Dang, N. H., & Morimoto, C. (2011) · Advances in clinical chemistry · doi:10.1016/b978-0-12-385855-9.00003-5 · Cited by 68 · see citing works

Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients

von Glehn, F., Farias, A. S., de Oliveira, A. C. P., Damasceno, A., Longhini, A. L. F., de Oliveira, E. C., Damasceno, B. P., Santos, L. M., & Brandão, C. O. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511428465 · Cited by 68 · see citing works

Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse

Longhini, A. L. F., von Glehn, F., Brandão, C. O., de Paula, R. F. O., Pradella, F. M., Moraes, A. S., Farias, A. S., de Oliveira, E. C., Quispe-Cabanillas, J. G., Horta, C. A., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-2 · Cited by 68 · see citing works

Ethnicity and prevalence of multiple sclerosis in east London

Albor, C., du Sautoy, T., Vanan, N. K., Turner, B. P., Boomla, K., & Schmierer, K. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516638746 · Cited by 66 · see citing works

Epigenetic Modifications and Therapy in Multiple Sclerosis

Aslani, S., Jafari, N., Javan, M. R., Karami, J., Ahmadi, M., & Jafarnejad, M. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8422-x · Cited by 67 · see citing works

Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms

Freiesleben, S., Hecker, M., Zettl, U. K., Fuellen, G., & Taher, L. (2016) · Scientific Reports · doi:10.1038/srep34512 · Cited by 66 · see citing works

Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews

Mentis, A. A., Dardiotis, E., Efthymiou, V., & Chrousos, G. P. (2021) · BMC Medicine · doi:10.1186/s12916-020-01873-7 · Cited by 65 · see citing works

Environmental factors and risk of multiple sclerosis: Findings from meta-analyses and Mendelian randomization studies

Belbasis, L., Bellou, V., Εvangelou, Ε., & Tzoulaki, I. (2019) · Multiple Sclerosis Journal · doi:10.1177/1352458519872664 · Cited by 66 · see citing works

Association between human herpesviruses and multiple sclerosis: A systematic review and meta-analysis

Khalesi, Z., Tamrchi, V., Razizadeh, M. H., Letafati, A., Moradi, P., Habibi, A., Habibi, N., Heidari, J., Noori, M., Samiei, M. N., et al. (2023) · Microbial Pathogenesis · doi:10.1016/j.micpath.2023.106031 · Cited by 69 · see citing works

Relationship of human herpes virus 6 and multiple sclerosis: A systematic review and meta‐analysis

Pormohammad, A., Azimi, T., Falah, F., & Faghihloo, E. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26000 · Cited by 65 · see citing works

Neuroimmune disorders of the central nervous system in children in the molecular era

Wells, E. M., Hacohen, Y., Waldman, A. T., Tillema, J. M., Soldatos, A. G., Ances, B. M., Benseler, S. M., Bielekova, B., Dale, R. C., Dalmau, J. O., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0024-9 · Cited by 65 · see citing works

Childhood Trauma in Multiple Sclerosis

Spitzer, C., Bouchain, M., Winkler, L. Y., Wingenfeld, K., Gold, S. M., Grabe, H. J., Barnow, S., Otte, C., & Heesen, C. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31824c2013 · Cited by 83 · see citing works

Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review

Goulden, R., Ibrahim, T., & Wolfson, C. M. (2014) · European Journal of Neurology · doi:10.1111/ene.12586 · Cited by 60 · see citing works

Comparative study of quality of life, anxiety, depression, and fatigue among patients with neuromyelitis optica spectrum disorder and multiple sclerosis: The first report from Iran

Barzegar, M., Badihian, S., Mirmosayyeb, O., Ashtari, F., Jamadi, M. S., Emami, S., Jahani, L., Safavi, A., & Shaygannejad, V. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.04.009 · Cited by 60 · see citing works

Inflammation as common link to progressive neurological diseases

Dias-Carvalho, A., Sá, S. I., Carvalho, F., Fernandes, E., & Costa, V. M. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03628-8 · Cited by 60 · see citing works

CAR Treg: A new approach in the treatment of autoimmune diseases

Beheshti, S. A., Shamsasenjan, K., Ahmadi, M., & Abbasi, B. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108409 · Cited by 58 · see citing works

Helicobacter pyloriinfection as a protective factor against multiple sclerosis risk in females

Fabis‐Pedrini, M. J., Seewann, A., Bennett, K., Wood, A. J. T., JAMES, I. R., Burton, J., Marshall, B. J., Carroll, W. M., & Kermode, A. G. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-309495 · Cited by 58 · see citing works

Estrogen Interactions With Lipid Rafts Related to Neuroprotection. Impact of Brain Ageing and Menopause

Marín, R., & Díaz, M. L. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00128 · Cited by 58 · see citing works

Can we prevent or treat multiple sclerosis by individualised vitamin D supply?

Dörr, J., Döring, A., & Paul, F. (2013) · The EPMA Journal · doi:10.1186/1878-5085-4-4 · Cited by 68 · see citing works

Epstein-Barr virus in oral shedding of children with multiple sclerosis

Yea, C., Tellier, R., Chong, P. M., Westmacott, G., Marrie, R. A., Bar‐Or, A., Banwell, B., & On behalf of the Canadian Pediatric Demyelinating Disease Network (2013) · Neurology · doi:10.1212/wnl.0b013e3182a841e4 · Cited by 57 · see citing works

A review on potential roles of vitamins in incidence, progression, and improvement of multiple sclerosis

Khosravi-Largani, M., Pourvali‐Talatappeh, P., Rousta, A., Karimi-Kivi, M., Noroozi, E., Mahjoob, A., Asaadi, Y., Shahmohammadi, A., Sadeghi, S., Shakeri, S., et al. (2018) · eNeurologicalSci · doi:10.1016/j.ensci.2018.01.007 · Cited by 59 · see citing works

Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives

Zivadinov, R., Ramanathan, M. K., Dolić, K., Marr, K., Karmon, Y., Siddiqui, A. H., Benedict, R. H. B., & Weinstock‐Guttman, B. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.117 · Cited by 56 · see citing works

Genetic Association of MiR-146a with Multiple Sclerosis Susceptibility in the Chinese Population

Li, Y., Chen, D., Wang, W., Ma, G., Cui, L., Zhou, H., Tao, H., Yao, L., Zhao, B., & Li, K. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369695 · Cited by 56 · see citing works

CCDC88B is a novel regulator of maturation and effector functions of T cells during pathological inflammation

Kennedy, J. M., Fodil, N., Torre, S., Bongfen, S. E., Olivier, J.-F., Leung, V., Langlais, D., Meunier, C., Berghout, J., Langat, P., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140455 · Cited by 56 · see citing works

A systematic review of morbidities suggestive of the multiple sclerosis prodrome

Yusuf, F. L. A., Ng, B. C., Wijnands, J. M. A., Kingwell, E., Marrie, R. A., & Tremlett, H. L. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1746645 · Cited by 54 · see citing works

Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis

Rivera, F. J., & Aigner, L. (2012) · Biological Research · doi:10.4067/s0716-97602012000300007 · Cited by 53 · see citing works

High rates of physician services utilization at least five years before multiple sclerosis diagnosis

Marrie, R. A., Yu, N., Wei, Y., Elliott, L. J., & Blanchard, J. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512471877 · Cited by 52 · see citing works

VDBP, CYP27B1, and 25-Hydroxyvitamin D Gene Polymorphism Analyses in a Group of Sicilian Multiple Sclerosis Patients

Agnello, L., Scazzone, C., Sasso, B. L., Bellia, C., Bivona, G., Realmuto, S., Brighina, F., Schillaci, R., Ragonese, P., Salemi, G., et al. (2016) · Biochemical Genetics · doi:10.1007/s10528-016-9783-4 · Cited by 52 · see citing works

Epstein–Barr virus and multiple sclerosis: association or causation?

Pakpoor, J., Giovannoni, G., & Ramagopalan, S. V. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.6 · Cited by 51 · see citing works

Vitamin D receptor binding, chromatin states and association with multiple sclerosis

Disanto, G., Sandve, G. K., Berlanga‐Taylor, A. J., Ragnedda, G., Morahan, J. M., Watson, C. T., Giovannoni, G., Ebers, G. C., & Ramagopalan, S. V. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds189 · Cited by 50 · see citing works

Reduced duration of breastfeeding is associated with a higher risk of multiple sclerosis in both Italian and Norwegian adult males: the EnvIMS study

Ragnedda, G., Leoni, S., Parpinel, M. T., Casetta, I., Riise, T., Myhr, K., Wolfson, C. M., & Pugliatti, M. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7704-9 · Cited by 48 · see citing works

Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis

Gabelic, T., Ramasamy, D. P., Weinstock-Guttman, B., Hagemeier, J., Kennedy, C., Melia, R., Hojnacki, D., Ramanathan, M., & Zivadinov, R. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3653 · Cited by 51 · see citing works

Antibody Cross-Reactivity in Auto-Immune Diseases

Trier, N. H., & Houen, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713609 · Cited by 47 · see citing works

The Multiple Sclerosis Prodrome: Evidence to Action

Tremlett, H. L., Munger, K. L., & Makhani, N. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.761408 · Cited by 44 · see citing works

From the prodromal stage of multiple sclerosis to disease prevention

Marrie, R. A., Allegretta, M., Barcellos, L. F., Bebo, B. F., Calabresi, P. A., Correale, J. D., Davis, B. G., Jager, P. L. D., Gasperi, C., Greenbaum, C. J., et al. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00686-x · Cited by 89 · see citing works

The multiple sclerosis prodrome

Makhani, N., & Tremlett, H. L. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00519-3 · Cited by 132 · see citing works

The multiple sclerosis prodrome: Emerging evidence, challenges, and opportunities

Tremlett, H. L., & Marrie, R. A. (2020) · Multiple Sclerosis Journal · doi:10.1177/1352458520914844 · Cited by 88 · see citing works

Anticipating Clinical Onset in Multiple Sclerosis: Challenges and Opportunities

Nociti, V., & Romozzi, M. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15120598 · Cited by 2 · see citing works